Hemoglobinopathias and thalassemias are t h e two major types o f i n h e r i t e d disorders o f hemoglobin i n man. While the hemoglobinopathias e x h i b i t q u a l i t a t i v e changes of t h e g l o b i n molecule, t h e thalassemias r e s u l t from an imbalance i n a-and non-a-globin chain production. I n recent years t h e s t r u c t u r a l features of the normal human g l o b i n genes as w e l l as t h e molecular l e s i o n s i n several hemoglobinopathias and many forms o f thalassemias have been determined by t h e a p p l i c a t i o n o f recombinant DNA technology. While g l o b i n gene d e l e t i o n s are t h e predominant underlying molecular defects i n a-thalassemia ayndroms, the m a j o r i t y o f hemoglobinopathias and B-thalassemias are due t o p o i n t mutations w i t h i n t h e respective g l o b i n gene regions.
For diagnostic purposes t h e i d e n t i f i c a t i o n o f mutant genes i n c e l l u l a r DNA i s t h e o r e t i c a l l y p o s s i b l e because o f t h e d i r e c t o r i n d i r e c t s p e c i f i c i t y o f r e s t r i c t i o n enzymes. A d i r e c t i d e n t if i c a t i o n o f the d e f e c t i v e gene can be made i f t h e mutation changed an enzyme's cleavage s i t e and thus changes the normal DNA r e s t r i c t i o n p a t t e r n . For example, t h e d i r e c t d e t e c t i o n o f t h e s i c k l e c e l l gene w i t h r e s t r i c t i o n enzyme Mst I 1 and t h e hemog l o b i n (Hb) M Milwaukee gene w i t h Sst I have r e c e n t l y been desc r i b e d (10,9,2,3,7).
An i n d i r e c t i d e n t i f i c a t i o n o f chromosomes t h a t c a r r y a mutant gene r e l i e s on t h e presence o f i n h e r i t e d DNA sequence polymorphisms w i t h i n t h e c e l l u l a r genome, g i v i n g r i s e t o v a r i a t i o n s i n r e s t r i c t i o n s i t e s . Examples of t h i s i n d i r e c t d i a g n o s t i c procedure are the i d e n t i f i c a t i o n o f d e f e c t i v e D-globin
genes, causing hemoglobinopathias (e.g. Hb Freiburg, Hb Koln, Hb Presbyterian (8,4,5) o r P-thalassemias (1,B)).
A t h i r d p o s s i b i l i t y t o i d e n t i f y chromosomes c a r r y i n g p o i n t
mutations o r small d e l e t i o n s r e l i e s on o l i g o n u c l e o t i d e mapping procedures t h a t have successfully been applied f o r diagnosis of some hemoglobinopathias and thalassemias. Here genotype a n a l y s i s r e l i e s on t h e d e t e c t i o n o f normal homozygotes, heterozygotes and d e f e c t i v e homozygotes e x h i b i t i n g t h e respective three s e t s o f intense, intermediate and missing band s i g n a l s upon h y b r i d i z a t i o n w i t h o l i g o n u c l e o t i d e s complementary t o t h e normal or the mutated gene sequence. These experimental c o n d i t i o n s can a l s o be used i n diseases w i t h an autosomal dominant i n h e r i t a n c e p a t t e r n as i n t h e Hb F r e i b u r g disorder, where normal homozygotes can be d i f f e re n t i a t e d from Hb F r e i b u r g p a t i e n t s (Horst e t a l . unpublished).
A l l these methods have been a p p l i e d f o r pre-and p o s t n a t a l d i a g n o s t i c purposes. I n genetic c o u n s e l l i n g they have been used together w i t h chorion biopsy o r amniocentesis t o provide p r e n a t a l diagnosis i n f a m i l i e s a t r i s k . I n the case o f a-thalassemias p r e n a t a l diagnosis might only be a p p
l i e d t o permit a mother w i t h a f e t u s w i t h hydrops f e t a l i s t o choose whether t o c a r r y t h e f e t u s through t h e f u l l 9 month of pregnancy. However, together w i t h hematological and family s t u d i e s DNA-analysis data are e s p e c i a l l y u s e f u l t o d i f f e r e n t i a t e between a-thalassemla-1 and a-thalassemia-2 p a t i e n t s and thus t o determine t h e exact diagnosis (6).
Refe- The w t a t i m s f o r Duchenne w s c u l a r dystrophy (DMD) and Becker w s c u l a r dystrophy (BW) have been l o c a l i s e d t o t h e srme region of t h e short arm of t h e h u m n X c h r m s m a t Xp21 by l lnkage a n a l y s i s t o b r i d g i n g CNA m r k e r s (1,2,3) . Linkage s t u d i e s shau t h z t t h e frequency o f r e c m b i n a t l m between w r k e r s i n t h i s r e g i c n i n t h e f a m i l i e s segregating f o r these d i s o r d e r s i s h i g h (4, 5, 6) . Q7e marker i n p a r t i c u l a r i s deleted i n b o t h a p a t i e n t s u f f e r i n g frar B ' D , c h r o n i c granulcnatous disease and r e t i n i t i s pigmentosa (7) and i n a P a t i e n t suffering frcm M D and g l y c e r o l kinase d e f i c i e nc y (81. The former has a v i s i b l e cytogenetic d e l e t i m . This marker i s l i n k e d a t a p p r o x l m t e l y lOcM f r a t h e M locus <5,6). An add i t i m a l marker cn t h e opposite s i d e of t h e WD and BMD l o c i a l s o w i t h i n Xp21 I s l i n k e d a t a s i m i l a r genetic distance (9) . A l t h m g h these two markers together can nau be used f o r antenatal diagnosis (lo), m l y a few fan1 1 i e s can be helped. b r e c l o s e l y I inked a r e being I d e n t i f i e d .
S t r a t e g i e s a r e nau being developed t o i s o l a t e a d d i t l m a l sequences l o c a l i s e d w i t h i n these d e l e t i m s (11) . These approaches should e v e n t u a l l y lead t o t h e i d e n t i f i c a t l m of t h e m l e c u l a r b a s i s of M*D and BMD and permit t h e i n v e s t l g a t i m o f t h e observed h i g h w t a t i m r a t e and t h e degree o f heterogeneity o f t h e m t a t i c n s a t t h e CNA l e v e l .
